Gut bacteria boosts breast cancer treatment? new trial launches
Disease control
Not yet recruiting
This phase 2 trial tests whether adding a live bacteria supplement (MO-03) to standard chemotherapy and immunotherapy (pembrolizumab) can improve outcomes for 50 people with early-stage triple-negative breast cancer. Participants take the supplement twice daily until surgery, the…
Phase: PHASE2 • Sponsor: Yuan Yuan • Aim: Disease control
Last updated May 17, 2026 04:09 UTC